On-Demand Webcast

Share

Program Content

Activities

  • NDMM at EHA 2024
    Experts Discuss Advances in Newly Diagnosed Multiple Myeloma: The Impact of More Intensive Therapy on Clinical Outcomes Test 1
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 17, 2024

    Expires: September 30, 2025

Faculty

cover img faculity

Michele Cavo, MD

Head, “Seràgnoli” Institute of Hematology
Director, Postgraduate Residency in Hematology
Full Professor of Hematology
Department of Medical and Surgical Sciences
Bologna University School of Medicine
Bologna, Italy

cover img faculity

Francesca Gay, MD, PhD

Associate Professor
Department of Molecular Biotechnology and Health Science
University of Torino
SC Ematologia 1
AOU Citta della Salute e della Scienza
Torino, Italy

cover img faculity

Timothy Scialla, MD

Associate Professor
Division of Pulmonary, Allergy, and Critical Care Medicine
Department of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia

PT Faculty

cover img faculity

John Mascarenhas, MD

Director
Center of Excellence in Blood Cancers and Myeloid Disorders
Director
Adult Leukemia Program
Leader
Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Josie Montegaard, MSN, AGPCNP-BC

Nurse Practitioner
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Paul G. Richardson, MD

Director of Clinical Research
Clinical Program Leader
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi